Patient tailored immunity transplant for the prevention of viral infections post haemopoietic stem cell transplantation

为患者量身定制免疫移植，预防造血干细胞移植后的病毒感染

• 批准号: nhmrc : 1010107
• 负责人: Prof David Gottlieb
• 金额: $ 37.87万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/patient-tailored-immunity-cell-transplantation/109461
• 关键词: Patient; tailored; immunity; transplant; prevention

Blood or bone marrow transplantation can cure leukaemia and related blood disorders, but patients are susceptible to infections in the period early after transplant. Infectious complications remain a leading cause of death among allogeneic transplant recipients. Our research aims to prevent the onset of infection using novel cell therapies to rapidly restore the immune system thus preventing the problems associated with the transplant process.

血液或骨髓移植可以治愈白血病和相关的血液疾病，但患者在移植后早期易受感染。感染性并发症仍然是同种异体移植受者死亡的主要原因。我们的研究旨在利用新的细胞疗法来预防感染的发生，从而快速恢复免疫系统，从而防止与移植过程相关的问题。